Clearmind reports improved nasal retention for its MEAI drug formulation
Go back to Clearmind reports improved nasal retention for its MEAI drug formulation| (NASDAQ: CMND) | Delayed: 1.06 +0.03 (2.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.03 | 52 Week High | $ | |||
| Open | $1.07 | 52 Week Low | $ | |||
| Day High | $1.09 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $ | |||
| Volume | 175,075 | |||||
